Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum  -Lactamases

L. Paterson, David; Ko, Wen‐Chien; von Gottberg, Anne; Mohapatra, Sunita; María Casellas, José; Goossens, Herman; Mülazımoğlu, Lütfiye; M. Trenholme, Gordon; P. Klugman, Keith; A. Bonomo, Robert; B. Rice, Louis; M. Wagener, Marilyn; G. McCormack, J.; L. Yu, Victor

doi:10.1086/420816

Public

Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -Lactamases

Published in Clinical Infectious Diseases • Jun 21, 2004

Authors:

David L. Paterson

Wen‐Chien Ko

Anne von Gottberg

Abstract

The prevalence of extended-spectrum beta -lactamase (ESBL) production by Klebsiella pneumonia approaches 50% in some countries, with particularly high rates in eastern Europe and Latin America. No randomized trials have ever been performed on treatment of bacteremia due to ESBL-producing organisms; ...

Subject

Bacteremia

Medicine

Klebsiella pneumoniae

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!